Skip to main content
Fig. 10 | Acta Neuropathologica Communications

Fig. 10

From: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Fig. 10

AD tau staging in LRRK2 mutation carriers compared to idiopathic Lewy body disorders. a Tau pathology in LRRK2 mutation carriers was categorized into classical Braak stages. One case, which did not have a clinical diagnosis of PD or PDD was excluded. b The proportion of LRRK2 mutation carriers in each Braak stage of tauopathy is shown for 11 cases with LRRK2 mutations (0: 18%; I-II: 18%; III-IV: 46%; V-VI: 18%) or 133 PD and PDD cases (0: 9%; I-II: 50%; III-IV: 22%; V-VI: 19%) published in a previous study [9]. The presence of tau pathology is similar between the two cohorts

Back to article page